MENU
+Compare
OCPNF
Stock ticker: OTC
AS OF
Jan 14 closing price
Price
$13.20
Change
+$0.20 (+1.54%)
Capitalization
14.62B

OCPNF stock forecast, quote, news & analysis

Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream... Show more

OCPNF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for OCPNF with price predictions
Jan 14, 2026

Momentum Indicator for OCPNF turns positive, indicating new upward trend

OCPNF saw its Momentum Indicator move above the 0 level on December 19, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 69 similar instances where the indicator turned positive. In of the 69 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for OCPNF just turned positive on December 22, 2025. Looking at past instances where OCPNF's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

OCPNF moved above its 50-day moving average on December 30, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for OCPNF crossed bullishly above the 50-day moving average on January 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Aroon Indicator for OCPNF entered a downward trend on December 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.156) is normal, around the industry mean (62.999). P/E Ratio (24.351) is within average values for comparable stocks, (38.331). OCPNF's Projected Growth (PEG Ratio) (3.160) is slightly higher than the industry average of (1.670). Dividend Yield (0.011) settles around the average of (0.018) among similar stocks. P/S Ratio (2.424) is also within normal values, averaging (39.852).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OCPNF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCPNF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
published Dividends

OCPNF paid dividends on June 03, 2021

Olympus Corp. OCPNF Stock Dividends
А dividend of $12.00 per share was paid with a record date of June 03, 2021, and an ex-dividend date of March 30, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.9B. The market cap for tickers in the group ranges from 1.86K to 217.36B. ABT holds the highest valuation in this group at 217.36B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 5%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was 24%. CYDX experienced the highest price growth at 983%, while BBNX experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 54%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was 61%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 77
Price Growth Rating: 59
SMR Rating: 87
Profit Risk Rating: 92
Seasonality Score: 27 (-100 ... +100)
View a ticker or compare two or three
OCPNF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
Shinjuku Monolith
Phone
+81 333402111
Employees
36520
Web
http://www.olympus.co.jp